Androgenicity-not serum testosterone-correlates best with COVID-19 outcome in European males.

Giovanelli, Luca; Quinton, Richard

Giovanelli, Luca; Quinton, Richard.

Giovanelli L; Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy; Department of Endocrinology, Diabetes & Metabolism, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK.
Quinton R; Department of Endocrinology, Diabetes & Metabolism, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK; Translational & Clinical Research Institute, University of Newcastle-upon-Tyne, UK. Electronic address: richard.quinton@ncl.ac.uk.

EBioMedicine ; 66: 103286, 2021 Apr.

Article in English | MEDLINE | ID: covidwho-1141719

Subject(s)

COVID-19; SARS-CoV-2/metabolism; Testosterone; COVID-19/genetics; COVID-19/metabolism; Europe; Humans; Male; Testosterone/genetics; Testosterone/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Testosterone / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Humans / Male Country/Region as subject: Europa Language: English Journal: EBioMedicine Year: 2021 Document Type: Article Affiliation country: J.ebiom.2021.103286

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google